{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:36:03Z","timestamp":1777887363696,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["MH CZ DRO VFN 64165"],"award-info":[{"award-number":["MH CZ DRO VFN 64165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["J3-50113"],"award-info":[{"award-number":["J3-50113"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0170"],"award-info":[{"award-number":["P1-0170"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymgme.2025.109191","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:08:22Z","timestamp":1752602902000},"page":"109191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of genetic variants associated with Fabry nephropathy progression using whole-exome sequencing"],"prefix":"10.1016","volume":"145","author":[{"given":"Tina","family":"Levstek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Vujkovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albina","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o-Paulo","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Dost\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark\u00e9ta","family":"\u0160afa\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheona","family":"Altarescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Trebu\u0161ak Podkraj\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2025.109191_bb0005","first-page":"325","article-title":"The genetics of angiokeratoma corporis diffusum (Fabry\u2019s disease) and its linkage relations with the Xg locus","volume":"17","author":"Opitz","year":"1965","journal-title":"Am. J. Hum. Genet."},{"issue":"21","key":"10.1016\/j.ymgme.2025.109191_bb0010","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109191_bb0015","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2025.109191_bb0020","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.ASN.0000016684.07368.75","article-title":"Renal pathology in Fabry disease","volume":"13","author":"Alroy","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2025.109191_bb0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109191_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of \u03b1-galactosidase a activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109191_bb0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ndt\/gfp554","article-title":"End-stage renal disease in patients with Fabry disease: natural history data from the Fabry registry","volume":"25","author":"Ortiz","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109191_bb0040","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109191_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1681\/ASN.2013050452","article-title":"Unraveling the role of podocyte turnover in glomerular aging and injury","volume":"25","author":"Wanner","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109191_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000369309","article-title":"Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria","volume":"129","author":"T\u00f8ndel","year":"2015","journal-title":"Nephron"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109191_bb0055","doi-asserted-by":"crossref","first-page":"e157782","DOI":"10.1172\/JCI157782","article-title":"Accumulation of alpha-synuclein mediates podocyte injury in Fabry nephropathy","volume":"133","author":"Braun","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109191_bb0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","article-title":"Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria","volume":"51","author":"T\u00f8ndel","year":"2008","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109191_bb0065","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1681\/ASN.2019050497","article-title":"Accumulation of globotriaosylceramide in podocytes in Fabry nephropathy is associated with progressive podocyte loss","volume":"31","author":"Najafian","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109191_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ckj\/sfab172","article-title":"Podocyturia in Fabry disease: a 10-year follow-up","volume":"15","author":"Vujkovac","year":"2021","journal-title":"Clin. Kidney J."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109191_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168346","article-title":"Urinary podocyte loss is increased in patients with Fabry disease and correlates with clinical severity of Fabry nephropathy","volume":"11","author":"Fall","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109191_bb0080","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.ejhg.5201184","article-title":"Remarkable variability in renal disease in a large Slovenian family with Fabry disease","volume":"12","author":"Verovnik","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109191_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10545-007-0716-6","article-title":"Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz severity score index for Fabry disease","volume":"31","author":"Altarescu","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109191_bb0090","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1212\/01.WNL.0000166000.24321.4F","article-title":"Effect of genetic modifiers on cerebral lesions in Fabry disease","volume":"64","author":"Altarescu","year":"2005","journal-title":"Neurology"},{"issue":"64","key":"10.1016\/j.ymgme.2025.109191_bb0095","doi-asserted-by":"crossref","first-page":"107558","DOI":"10.18632\/oncotarget.22505","article-title":"Genetic variants associated with Fabry disease progression despite enzyme replacement therapy","volume":"8","author":"Scionti","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ymgme.2025.109191_bb0100","first-page":"1287","article-title":"Prediction of regulatory SNPs in putative minor genes of the neuro-cardiovascular variant in Fabry reveals insights into autophagy\/apoptosis and fibrosis","volume":"11","author":"Ruiz Ramirez","year":"2022","journal-title":"Biology (Basel)"},{"issue":"14","key":"10.1016\/j.ymgme.2025.109191_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34357","article-title":"Genome-wide expression analysis in a Fabry disease human podocyte cell line","volume":"10","author":"Snanoudj","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109191_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","article-title":"European expert consensus statement on therapeutic goals in Fabry disease","volume":"124","author":"Wanner","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109191_bb0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2025.109191_bb0120","article-title":"A guide to gene-disease relationships in nephrology","author":"Stark","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109191_bb0125","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41581-020-0298-1","article-title":"Unravelling the complex genetics of common kidney diseases: from variants to mechanisms","volume":"16","author":"Sullivan","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109191_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/ndt\/gfad209","article-title":"Genome-wide association studies reconstructing chronic kidney disease","volume":"39","author":"Fountoglou","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109191_bb0135","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS \u2013 Fabry outcome survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109191_bb0140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1681\/ASN.0000000000000066","article-title":"Novel genetic variants associated with chronic kidney disease progression","volume":"34","author":"Han","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109191_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajhg.2023.12.017","article-title":"Regulatory features aid interpretation of 3\u2019UTR variants","volume":"111","author":"Romo","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109191_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/475731","article-title":"Before it gets started: regulating translation at the 5\u2019 UTR","volume":"2012","author":"Araujo","year":"2012","journal-title":"Comp. Funct. Genomics"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109191_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.31083\/j.fbs1601004","article-title":"Decoding non-coding variants: Recent approaches to studying their role in gene regulation and human diseases","volume":"16","author":"Pena-Martinez","year":"2024","journal-title":"Front. Biosci. (Schol Ed)"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109191_bb0160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109191_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"81","author":"Pavenst\u00e4dt","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymgme.2025.109191_bb0170","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1038\/ncomms10822","article-title":"FAT1 mutations cause a glomerulotubular nephropathy","volume":"7","author":"Gee","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109191_bb0175","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.ekir.2021.01.023","article-title":"Expanding the spectrum of FAT1 nephropathies by novel mutations that affect hippo signaling","volume":"6","author":"Fabretti","year":"2021","journal-title":"Kidney Int Rep."},{"issue":"474","key":"10.1016\/j.ymgme.2025.109191_bb0180","doi-asserted-by":"crossref","first-page":"eaaf8165","DOI":"10.1126\/scisignal.aaf8165","article-title":"YAP-mediated mechanotransduction determines the podocyte\u2019s response to damage","volume":"10","author":"Rinschen","year":"2017","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109191_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003380","article-title":"Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development","volume":"9","author":"Reginensi","year":"2013","journal-title":"PLoS Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:09:54Z","timestamp":1777608594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1096719225001829"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109191","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of genetic variants associated with Fabry nephropathy progression using whole-exome sequencing","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109191"}}